LLS Innovations in Research: Blood Cancers and Beyond (LIVE STREAM LINK - http://cdn.digitalservices.online/ASH/)
 

Panel 1 - Beat AML: Progress in Treating Acute Myeloid Leukemia

MODERATOR: RON WINSLOW
Former Deputy Bureau Chief, Health and Science, The Wall Street Journal

ERKUT BAHCECI, MD
Vice President, Astellas Pharma

JOHN BYRD, MD
D. Warren Brown Chair, Leukemia Research, The Ohio State University Comprehensive Cancer Center

BRIAN DRUKER, MD
Director, OHSU Knight Cancer Institute; Investigator, Howard Hughes Medical Institute

ANN T. FARRELL, MD
Division Director, Hematology Products, Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

MARINA KONOPLEVA, MD, PhD
Chief, Leukemia Biology Research, Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center

KIMBERLY STEGMAIER, MD
Associate Professor of Pediatrics, Harvard Medical School; Ted Williams Chair, Dana-Farber Cancer Institute


Panel 2 - 
Beyond Blood Cancer: Blood Cancer Research Advances Helping Other Patients

MODERATOR: JOHN TORRES, MD
Medical Correspondent, NBC News

SELINA CHEN-KIANG, PhD
Professor of Pathology and Laboratory Medicine, Immunobiology and Microbial Pathogenesis, Weill Cornell Medicine

LOUIS DEGENNARO, PhD
President and Chief Executive Officer, The Leukemia & Lymphoma Society

BENJAMIN L. EBERT, MD, PhD
Professor of Medicine, Harvard Medical School; 
Chair of Medical Oncology, Dana-Farber Cancer Institute

RONALD LEVY, MD
Summer Professor of Medicine and Program Leader for Lymphoma, Stanford University School of Medicine

VALERIE FIORDILINO MASLOW, PA-C
Hematology/Oncology Physician Assistant, Cancer Center of South Florida
Multiple sclerosis patient benefiting from a leukemia therapy